RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
Psychological factors and quality of life in inflammatory bowel diseases patients: the Psycho study
2017-01-01 Vegni, E; Gilardi, D; Corro, Be; Menichetti, J; Leone, D; Allocca, M; Bonovas, S; Furfaro, F; Danese, S; Fiorino, G
Rapid detection of anti-infliximab antibodies in inflammatory bowel disease patients treated with the reference biologic or the biosimilar CT-P13: performance comparison with ELISA
2017-01-01 Fiorino, G; Ametzazurra, A; Nagore, D; Hernandez, Am; Torres, N; Radice, S; Gilardi, D; Correale, C; Allocca, M; Furfaro, F; Alfieri, M; Pascual, J; Recalde, X; Martinez, A; Danese, S
RAPID DETECTION OF ANTI-INFLIXIMAB ANTIBODIES IN INFLAMMATORY BOWEL DISEASE PATIENTS TREATED WITH THE REFERENCE BIOLOGIC OR THE BIOSIMILAR CT-P13: PERFORMANCE COMPARISON WITH ELISA
2017-01-01 Fiorino, G; Ametzazurra, A; Nagore, D; Hernandez, Am; Torres, N; Radice, S; Gilardi, D; Correale, C; Allocca, M; Furfaro, F; Alfieri, Mf; Pascual, J; Recalde, X; Martinez, A; Danese, S
Research gaps in diet and nutrition in inflammatory bowel disease. A topical review by ECCO
2017-01-01 Boneh, Rs; Levine, A; Lomer, M; Wierdsma, N; Alan, P; Fiorino, G; Gatti, S; Jonkers, D; Kierkus, J; Katsanos, Kh; Melgar, S; Yuksel, Es; Whelan, K; Wine, E; Gerasimidis, K
Response Evaluation and Safety of Thiopurines in the Treatment of Inflammatory Bowel Diseases (IBD)
2011-01-01 Costantino, G; Furfaro, F; Belvedere, A; Fiorino, G; Alibrandi, A; Fries, W
Risk Factor Analysis for Therapy Related Adverse Events and Infections in Elder Patients With Inflammatory Bowel Disease; An Analysis From the iG-IBD Aged Study
2015-01-01 Fries, W; Viola, A; Monterubbianesi, R; Manetti, N; Frankovic, I; Pugliese, D; Aratari, A; Cappello, M; Coppola, M; Cantoro, L; Saibeni, S; Principi, M; Furfaro, F; Fiorino, G; Mocci, G; Castiglione, F; Scalisi, G; Calella, F; Magarotto, A; Caprioli, F; Casella, G; Samperi, L; Inserra, G; Privitera, Ac; Danese, S; Ardizzone, S; Papi, C; Armuzzi, A; Kohn, A; Bossa, F; D'Inca, R; Annese, V; Alibrandi, A; Costantino, G
STIMULATION OF CYP450-MEDIATED omega-3 DOCOSAHEXAENOIC ACID (DHA) METABOLISM VIA MFSD2A AS A NOVEL THERAPY FOR INFLAMMATORY BOWEL DISEASE
2017-01-01 Ungaro, F; Tacconi, C; Correale, C; Massimino, L; Corsetto, P; Fonteyne, P; Piontini, A; Calcaterra, F; Della Bella, S; Spinelli, A; Carvello, M; Rizzo, A; Vetrano, S; Fiorino, G; Furfaro, F; Garzarelli, V; Maddipati, Kr; D'Alessio, S; Danese, S
Stimulation of CYP450-mediated omega-3 docosahexaenoic acid metabolism via MFSD2A as a novel therapy for inflammatory bowel disease
2017-01-01 Ungaro, F; Tacconi, C; Correale, C; Massimino, L; Corsetto, P; Piontini, A; Fonteyne, P; Calcaterra, F; Della Bella, S; Spinelli, A; Carvello, M; Rizzo, A; Vetrano, S; Fiorino, G; Furfaro, F; Maddipati, Kr; D'Alessio, S; Danese, S
Switching from infliximab originator to CT-P13 is not related to increased immunogenicity in IBD patients: a prospective case-control study
2017-01-01 Fiorino, G; Radice, S; Gilardi, D; Correale, C; Allocca, M; Furfaro, F; Alfieri, M; Nagore, D; Del Rio, L; Pascual, J; Martinez, A; Danese, S
SWITCHING FROM INFLIXIMAB ORIGINATOR TO CT-P13 IS NOT RELATED TO INCREASED IMMUNOGENICITY IN IBD PATIENTS: A PROSPECTIVE CASE-CONTROL STUDY
2017-01-01 Fiorino, G; Radice, S; Gilardi, D; Correale, C; Allocca, M; Furfaro, F; Alfieri, Mf; Nagore, D; del Rio, L; Pascual, J; Martnez, A; Danese, S
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Psychological factors and quality of life in inflammatory bowel diseases patients: the Psycho study | 1-gen-2017 | Vegni, E; Gilardi, D; Corro, Be; Menichetti, J; Leone, D; Allocca, M; Bonovas, S; Furfaro, F; Danese, S; Fiorino, G | |
| Rapid detection of anti-infliximab antibodies in inflammatory bowel disease patients treated with the reference biologic or the biosimilar CT-P13: performance comparison with ELISA | 1-gen-2017 | Fiorino, G; Ametzazurra, A; Nagore, D; Hernandez, Am; Torres, N; Radice, S; Gilardi, D; Correale, C; Allocca, M; Furfaro, F; Alfieri, M; Pascual, J; Recalde, X; Martinez, A; Danese, S | |
| RAPID DETECTION OF ANTI-INFLIXIMAB ANTIBODIES IN INFLAMMATORY BOWEL DISEASE PATIENTS TREATED WITH THE REFERENCE BIOLOGIC OR THE BIOSIMILAR CT-P13: PERFORMANCE COMPARISON WITH ELISA | 1-gen-2017 | Fiorino, G; Ametzazurra, A; Nagore, D; Hernandez, Am; Torres, N; Radice, S; Gilardi, D; Correale, C; Allocca, M; Furfaro, F; Alfieri, Mf; Pascual, J; Recalde, X; Martinez, A; Danese, S | |
| Research gaps in diet and nutrition in inflammatory bowel disease. A topical review by ECCO | 1-gen-2017 | Boneh, Rs; Levine, A; Lomer, M; Wierdsma, N; Alan, P; Fiorino, G; Gatti, S; Jonkers, D; Kierkus, J; Katsanos, Kh; Melgar, S; Yuksel, Es; Whelan, K; Wine, E; Gerasimidis, K | |
| Response Evaluation and Safety of Thiopurines in the Treatment of Inflammatory Bowel Diseases (IBD) | 1-gen-2011 | Costantino, G; Furfaro, F; Belvedere, A; Fiorino, G; Alibrandi, A; Fries, W | |
| Risk Factor Analysis for Therapy Related Adverse Events and Infections in Elder Patients With Inflammatory Bowel Disease; An Analysis From the iG-IBD Aged Study | 1-gen-2015 | Fries, W; Viola, A; Monterubbianesi, R; Manetti, N; Frankovic, I; Pugliese, D; Aratari, A; Cappello, M; Coppola, M; Cantoro, L; Saibeni, S; Principi, M; Furfaro, F; Fiorino, G; Mocci, G; Castiglione, F; Scalisi, G; Calella, F; Magarotto, A; Caprioli, F; Casella, G; Samperi, L; Inserra, G; Privitera, Ac; Danese, S; Ardizzone, S; Papi, C; Armuzzi, A; Kohn, A; Bossa, F; D'Inca, R; Annese, V; Alibrandi, A; Costantino, G | |
| STIMULATION OF CYP450-MEDIATED omega-3 DOCOSAHEXAENOIC ACID (DHA) METABOLISM VIA MFSD2A AS A NOVEL THERAPY FOR INFLAMMATORY BOWEL DISEASE | 1-gen-2017 | Ungaro, F; Tacconi, C; Correale, C; Massimino, L; Corsetto, P; Fonteyne, P; Piontini, A; Calcaterra, F; Della Bella, S; Spinelli, A; Carvello, M; Rizzo, A; Vetrano, S; Fiorino, G; Furfaro, F; Garzarelli, V; Maddipati, Kr; D'Alessio, S; Danese, S | |
| Stimulation of CYP450-mediated omega-3 docosahexaenoic acid metabolism via MFSD2A as a novel therapy for inflammatory bowel disease | 1-gen-2017 | Ungaro, F; Tacconi, C; Correale, C; Massimino, L; Corsetto, P; Piontini, A; Fonteyne, P; Calcaterra, F; Della Bella, S; Spinelli, A; Carvello, M; Rizzo, A; Vetrano, S; Fiorino, G; Furfaro, F; Maddipati, Kr; D'Alessio, S; Danese, S | |
| Switching from infliximab originator to CT-P13 is not related to increased immunogenicity in IBD patients: a prospective case-control study | 1-gen-2017 | Fiorino, G; Radice, S; Gilardi, D; Correale, C; Allocca, M; Furfaro, F; Alfieri, M; Nagore, D; Del Rio, L; Pascual, J; Martinez, A; Danese, S | |
| SWITCHING FROM INFLIXIMAB ORIGINATOR TO CT-P13 IS NOT RELATED TO INCREASED IMMUNOGENICITY IN IBD PATIENTS: A PROSPECTIVE CASE-CONTROL STUDY | 1-gen-2017 | Fiorino, G; Radice, S; Gilardi, D; Correale, C; Allocca, M; Furfaro, F; Alfieri, Mf; Nagore, D; del Rio, L; Pascual, J; Martnez, A; Danese, S |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 4 Contributo in Atti di Convegno ... 37
- 4 Contributo in Atti di Convegno ... 37
Data di pubblicazione
- 2019 1
- 2017 19
- 2016 5
- 2015 1
- 2014 2
- 2013 3
- 2012 2
- 2011 3
- 2009 1
Rivista
- GASTROENTEROLOGY 19
- JOURNAL OF CROHN'S AND COLITIS 10
- GUT 3
- JOURNAL OF CROHN'S AND COLITIS SU... 3
- DIGESTIVE AND LIVER DISEASE 1
- JOURNAL OF GASTROENTEROLOGY AND H... 1
Lingua
- eng 9
- und 1
Accesso al fulltext
- no fulltext 37